Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)

Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)

US Patent 12295985 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapy for glaucoma and optic neuropathy by targeting colony stimulating factor2025
Assessing visual function2025
Therapy for glaucoma and optic neuropathy by targeting colony stimulating factor2023
Alpha-aminoadipate for treatment of vision loss and restoring sight2023
Radiation curable compositions with anti-stain properties2022
Methods for promoting neuronal outgrowth by insulin-like growth factor binding p2020
Methods for promoting neuronal outgrowth by insulin-like growth factor binding p2020
Alpha-aminoadipate for treatment of vision loss and restoring sight2020
Enzymatic treatment of alginate to reduce membrane fouling for water or wastewat2016